Trevi Therapeutics Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Updates

Go back to Trevi Therapeutics Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Updates
(NASDAQ: TRVI) Delayed: 18.03 +0.32 (1.81%)
Previous Close $17.71    52 Week High
Open $17.49    52 Week Low
Day High $18.06    P/E N/A 
Day Low $17.34    EPS
Volume 905,407